A Tribute to The Honorable Daniel Oliver
A Tribute to The Honorable Daniel Oliver Pacific Research Institute Chairman Emeritus and Board Member since 1991 The Honorable Daniel Oliver was a rare and remarkable man—steadfast in market-based principles and freedom, generous in spirit, and deeply devoted to the ...
Unauthorized GLP-1 Knockoffs Risk Patient Safety and Future Innovation, New PRI Brief Warns
As federal regulators intensify enforcement against companies selling unauthorized knockoffs of blockbuster weight-loss drugs, a new Pacific Research Institute brief warns that the booming GLP-1 knockoff market is creating patient safety risks while undermining future breakthrough medicines. “GLP-1s are among ...
Trump’s healthcare fraud crackdown is paying off
Federal prosecutors recently announced that they’d charged 455 defendants in connection with more than $6.5 billion in alleged fraud involving Medicare, Medicaid, and other public healthcare programs. The news serves as a vivid reminder of just how much taxpayer money ...
Spending Watch
Spending Watch: Newsom’s Final Budget Defers the Difficult Budget Decisions to California’s Next Governor
Newsom’s Final Budget Defers the Difficult Budget Decisions to California’s Next Governor Wayne Winegarden July 2026 The FY2026-27 Budget Basics Gov. Newsom has signed the FY2026-27 budget – Newsom’s final one as governor. He claims the budget “prioritizes fiscal restraint” ...
New Study: States Could Save Up to $1.8 Billion Annually by Prioritizing Lower-Cost Biosimilar Medicines
At a time when states across the country are grappling with significant budget challenges, a new study from the Center for Medical Economics and Innovation at the Pacific Research Institute – the nonpartisan, California-based, free market think tank – finds ...
Trending Topics
- Most Popular
- Crime
- Drug Importation
- Drug Innovation
- Homelessness
- Inflation
- Single Payer
PBM’s Drug Cut Exceeds the Total Cost of Medicines In Most Other Countries
Another fundamental problem is these comparisons rely on U.S. medicines’ gross (or list) price. But list prices do not account for the complex U.S. drug ...
San Francisco’s Recovery—and Its Lessons
A few years ago, I was one of San Francisco’s harshest critics. Writing for the Pacific Research Institute, I documented rising crime, retail theft, open-air ...
Unauthorized GLP-1 Knockoffs Risk Patient Safety and Future Innovation, New PRI Brief Warns
As federal regulators intensify enforcement against companies selling unauthorized knockoffs of blockbuster weight-loss drugs, a new Pacific Research Institute brief warns that the booming GLP-1 ...
About PRI
The Pacific Research Institute for Public Policy promotes the principles of individual freedom and personal responsibility. The Institute believes these principles are best encouraged through policies that emphasize a free economy, private initiative, and limited government.
Worthy policy goals with such broad impact are not easily attained, and they require sustained effort and struggle. Together with its alliance of dedicated supporters, PRI is committed to leading the way toward a more free and prosperous future for all.
2025 By the Numbers
Op-Eds
0
Hosted Events
0
Radio and TV Appearances
0
Print and Online Media Hits
0